Management of women who have continued to use Nexplanon® beyond the three year product licence - December 2016

Posted 5 December 2016

Date: 05 Dec 2016

Type: FSRH Clinical Guidance and Clinical Statements

Author: FSRH Clinical Effectiveness Unit

A recently published multinational trial reports no pregnancies among 311 women who extended use of their existing Nexplanon® to four years and 204 women who continued to five years of use.

The CEU consider that evidence is currently insufficient to routinely recommend extended use of Nexplanon beyond the three year product licence. Advice is given regarding management of women presenting after unprotected sexual intercourse during extended use.

Read the news item below for more information.